• Highlights of the Zhongshan-Specific Colorectal Cancer Forum with Emphasis on Precision Diagnosis, Treatment, and Public Screening

    The Guangzhou Colorectal Cancer Summit Forum and the 22nd Guangdong Provincial Colorectal Cancer Academic Conference were successfully held from August 5-10, 2024. Reporters from Oncology Frontier conducted an in-depth interview with the conference chair, Dr. Gong Chen from the Sun Yat-sen University Cancer Center, focusing on the highlights of the conference and the precision diagnosis…

  • B J Hepatol | Xiaolong Qi / Jie Shen: High Prevalence o+f Liver Fibrosis in the General Population of China

    On July 28, 2024, the Journal of Hepatology (CAS 1st Tier, IF: 26.8), a leading international journal in hepatology, published a prospective study conducted by the LiverHome research group. This study, based on the general population in China, assessed the prevalence of fatty liver disease and liver fibrosis, providing the latest evidence for chronic liver…

  • Hepatol Int | Higher Risk of Liver-Related Mortality in Lean MAFLD Patients Compared to Non-Lean Patients

    While metabolic-associated fatty liver disease (MAFLD) has traditionally been associated with obesity and metabolic syndrome, recent studies indicate that a significant prevalence of MAFLD also exists among lean individuals. These patients typically do not exhibit traditional obesity-related risk factors, such as a high body mass index (BMI) or large waist circumference, yet their livers are…

  • AIDS 2024 | WHO-Recommended Triple HIV Testing Algorithm Significantly Improves Diagnostic Accuracy

    In 2023, the World Health Organization (WHO) recommended that countries with low HIV prevalence adopt a triple testing approach to confirm HIV-positive diagnoses. Specifically, WHO advises countries with an HIV prevalence below 5% to use three consecutive tests to ensure a 99% diagnostic accuracy. The proportion of positive HIV tests in a population can impact…

  • AIDS Dialogue | Acute HIV Infection Detection: A Critical Battle to Block Transmission and Improve Prognosis

    Early detection and treatment of HIV play a crucial role in AIDS prevention and control. A critical battlefield is emerging with increasing importance—the timely detection of acute HIV infection (AHI). AHI refers to the period from the entry of the HIV virus into the body until antibodies become detectable, typically occurring within a few weeks…

  • AIDS Interview | High-Risk Factors and Strategies for HIV Vertical Transmission

    On the global journey to eliminate HIV infections among children, different countries and regions face distinctly different challenges. Recently, at the AIDS2024 conference, Dr. Kira Elsbernd from the University of Munich in Germany delivered a special report on the risk factors involved in HIV vertical transmission and was interviewed by Infectious Diseases Frontier(IIDF). Dr. Elsbernd…

  • AIDS Exclusive Interview | Caring for Children with HIV: Advances in Pediatric HIV Care

    Pediatric care and treatment for children with HIV infection have always been a critical component in the global fight against AIDS. Recently, at the AIDS2024 conference, Dr. Anna Turkova from University College London shared her insights with Infectious Diseases Frontier(IIDF) on the breakthrough advancements in pediatric HIV care. She highlighted that the detection and diagnosis…

  • Dr. Rumi: Analysis of Effective Intervention Methods for MAFLD and HCC

    Recently, Combined GIHep&SHC 2024 was successfully held in Singapore. Experts in the field of liver disease from around the world gathered together to discuss the latest developments, challenges, and opportunities in liver disease. Reporters from Hepatology Digest rushed to the scene and conducted interviews with multiple experts. During the interview, Dr. Md Shofequnnabi Rumi, Assistant…